AdvanSix Inc. and Arxada have successfully settled all outstanding patent infringement suits, reaching a comprehensive agreement through amicable discussions. This resolution addresses all pending patent disputes worldwide. AdvanSix is the owner of EZ-BLOX® Anti-Skinning Agent, which includes the key component 2-pentanone oxime ("2PO"). This component's use as an additive in alkyd-based coating compositions is covered by patent EP 3 286 270, validated in numerous European countries and valid until April 2036. As part of the agreement, Troy will source EZ-BLOX 2PO from AdvanSix and co-brand downstream sales with the EZ-BLOX® and Troymax® Antiskin MP marks. The agreement terms remain confidential.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AdvanSix Inc. published the original content used to generate this news brief on August 19, 2025, and is solely responsible for the information contained therein.